Ignyta, Lieden University team on RA biomarker research

Ignyta will work with Leiden University Medical Center on new biomarker research involving patients with early synovitis and rheumatoid arthritis. The goal of the work is to develop a diagnostic test for patients with early-stage rheumatoid arthritis, and so the joint effort will focus on assessing epigenetic biomarker signatures for both conditions. Such a diagnostic, ideally, will be designed with both high specificity and high sensitivity. Ignyta launched two years ago and is based in San Diego. Release

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.